Rest Of Europe HLA Typing Market (2025-2030)
The Rest Of Europe HLA Typing Market was valued at $10.4 Million in 2025 and projected to reach to $11.6 Million by 2030, representing a compound annual growth rate of CAGR 2.2%. Rest Of Europe's HLA Typing Market is experiencing steady growth as healthcare systems increasingly recognize the importance of HLA typing in transplantation and immunological diagnostics.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Europe HLA Typing Market Trends and Insights
- Rest Of Europe encompasses a diverse set of healthcare systems with varying adoption rates for HLA typing technologies, driven by transplantation programs, immunological diagnostics, and disease association studies.
- The moderate growth trajectory in Rest Of Europe reflects steady demand from organ transplant centers and immunology laboratories, though market expansion is tempered by regulatory complexities and healthcare budget constraints across the region. Rest Of Europe's HLA Typing Market is characterized by established clinical practices in transplantation and emerging applications in personalized medicine and pharmacogenomics.
- Between 2025 and 2030, Rest Of Europe will experience incremental market expansion supported by improved laboratory infrastructure and increased awareness of HLA testing benefits.
- The region's growth rate of 2.2% CAGR is notably lower than global benchmarks, indicating a mature but stable market with limited disruptive innovation drivers compared to other European segments..
Key Market Statistics
- CAGR (2025-2030) CAGR 2.2%
- Market Size, 2025 ~USD 10.4 Million
- Forecast, 2030 ~USD 11.6 Million
- Country Rest Of Europe
Rest Of Europe HLA Typing Market Overview
Market Valuation :
Rest Of Europe HLA Typing Market is valued at USD 10.4 million in 2025, with steady growth projected to USD 11.6 million by 2030.
Growth Trajectory :
The region demonstrates a CAGR of 2.2% from 2025-2030, reflecting moderate but consistent adoption of HLA typing technologies across diverse European healthcare systems.
Healthcare Diversity :
Rest Of Europe encompasses varied healthcare infrastructures with differing adoption rates for HLA typing, influenced by transplantation programs and immunological diagnostic capabilities.
Clinical Applications :
Market growth is driven by transplantation programs, immunological diagnostics, disease association studies, and increasing demand for precision medicine in smaller European markets.
Rest Of Europe HLA Typing Market Dynamics
- The region's diverse healthcare infrastructure presents both opportunities and challenges, with varying levels of technology adoption across different countries.
- Smaller European nations are gradually investing in advanced diagnostic capabilities, supported by growing transplantation programs and clinical research initiatives. The 2.2% CAGR reflects a conservative but sustainable growth pattern, driven by improving healthcare standards and increased awareness of HLA typing's clinical significance.
- Future expansion will likely be supported by regulatory harmonization across European markets, enhanced reimbursement policies, and collaborative transplantation networks.
- Investment in laboratory infrastructure and training will be critical to accelerating adoption in underserved regions..
Related Ecosystem
Key Takeaways
- Rest Of Europe HLA Typing Market valued at USD 10.4 million in 2025, growing to USD 11.6 million by 2030 at 2.2% CAGR
- Rest Of Europe demonstrates slower growth compared to global market, reflecting mature healthcare infrastructure and established clinical protocols
- Transplantation programs and immunological diagnostics remain primary drivers of HLA typing demand across Rest Of Europe
- Rest Of Europe market faces headwinds from regulatory fragmentation and budget constraints, limiting rapid expansion through 2030
HLA Typing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | COMMERCIAL SERVICE PROVIDERS (End User) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6% from 2025 to 2030 |
| Largest Segment | DIAGNOSTIC APPLICATIONS (Application) |
| Market Size Base Year (Billions) | ~USD 1.72 (2025) |
| Revenue Forecast (Billions) | ~USD 2.3 (2030) |
| Segments Covered | Product & Service, Technology, Type, Application, End User, Diagnostic Application |
Rest Of Europe HLA Typing Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Instruments
- Reagents & Consumables
- Software & Services
By Technology
- Molecular Assay Technologies
- Non-Molecular Assay Technologies
By Type
- Cancer Diagnosis & Prevention
- Donor-Recipient Cross-Matching
- Infectious Disease Testing
- Next-Generation Sequencing
- Other Diagnostic Applications
- Other Pcr-Based Molecular Assays
- Other Sequencing-Based Molecular Assays
- Pcr-Based Molecular Assays
- Real-Time Pcr
- Sanger Sequencing
- Sequence-Specific Oligonucleotide-Pcr
- Sequence-Specific Primar-Pcr
- Sequence-Specific Primer-Pcr
- Sequencing-Based Molecular Assays
- Transfusion Therapy
By Application
- Diagnostic Applications
- Research Applications
By End User
- Commercial Service Providers
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
By Diagnostic Application
- Cancer Diagnosis & Prevention
- Donor-Recipient Cross-Matching
- Infectious Disease Testing
- Other Diagnostic Applications
- Transfusion Therapy
Target Audience
- Diagnostic Equipment Manufacturers : Need regional market data to identify expansion opportunities in Rest Of Europe and understand adoption barriers in smaller healthcare systems.
- Healthcare System Administrators : Require market insights to justify investments in HLA typing infrastructure and benchmark their region's adoption rates against European peers.
- Transplantation Program Directors : Seek data on HLA typing capabilities and market trends to optimize transplantation outcomes and coordinate with regional diagnostic networks.
- In Vitro Diagnostics Companies : Need Rest Of Europe-specific market intelligence to develop localized product strategies and identify partnership opportunities with regional healthcare providers.
- Healthcare Investment Firms : Require detailed market forecasts and regional analysis to evaluate investment potential in diagnostic companies and healthcare infrastructure across Rest Of Europe.
Key Companies in the Rest Of Europe HLA Typing Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BGI GENOMICS | China | Public Company | Sequencing-based HLA services (NGS, immune repertoire, WES/WGS-derived typing),Reagents & consumables for HLA workflows,Instruments (sequencers and related hardware used for HLA), |
| BECTON DICKINSON AND CO | United States | Public Company | Instruments,Reagents,Software, |
| BD | United States | Public Company | Instruments,Reagents,Software, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Sequencing-based HLA (NGS, Sanger),PCR-based HLA (SSO, SSP, Real-time),Software and Informatics, |
| ILLUMINA, INC. | United States | Public Company | Sequencing Instruments (NGS platforms used for HLA typing),Sequencing Reagents, Flow Cells, and Library Prep for HLA,Software and DRAGEN-based Secondary Analysis for HLA, |
| QIAGEN | Netherlands | Public Company | Reagents & Consumables (PCR, NGS, sample technologies for HLA workflows),Instruments (PCR, NGS-related, automation, QC),Software & Bioinformatics (HLA analysis, SaaS, interpretation), |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Reagents & Consumables (PCR and sequencing HLA kits),Instruments (PCR, sequencing-adjacent, and automation),Software & Informatics (HLA analysis, LIS connectivity), |
| F. HOFFMANN-LA ROCHE LTD | United States | ||
| CAREDX, INC. | United States | Public Company | HLA Typing Reagents & Assays (PCR SSO/SSP, Real-time, NGS, Sanger),Instruments & NGS Workflow Components,Software (Ottr, HLA Data Systems, XynQAPI, MedActionPlan, others), |
| DIASORIN S.P.A. | Italy | Public Company | Instruments,Reagents,Software, |
| EUROBIO SCIENTIFIC | France | Public Company | Reagents (PCR and NGS HLA typing),Software (HLA typing analysis and reporting),Instruments (sequencers, ancillary lab systems), |
BGI GENOMICS
BGI Genomics is a Chinese public company founded in 1999 that employs 3,580 people. The company operates in the genomics and genetic sequencing sector.
BECTON DICKINSON AND CO
Becton Dickinson and Co is a United States-based public company founded in 1897 with 72,000 employees. The company operates in the medical devices and diagnostics sector.
BD
BD is a United States-based public company founded in 1897 with 72,000 employees. The company operates in the medical devices and diagnostics sector.
THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. The company operates in the life sciences and diagnostics industry.
ILLUMINA, INC.
Illumina, Inc. is a United States-based public company founded in 1998 with 8,625 employees. The company specializes in DNA sequencing and genetic analysis technologies.
QIAGEN
QIAGEN is a Netherlands-based public company founded in 1984 with 5,500 employees. The company operates in the molecular diagnostics and life sciences sector.
BIO-RAD LABORATORIES, INC.
Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research and clinical diagnostics products.
F. HOFFMANN-LA ROCHE LTD
Insufficient data available to provide a business description for this company.
CAREDX, INC.
CareDx, Inc. is a United States-based public company founded in 1998 with 763 employees. The company operates in the molecular diagnostics and transplant monitoring sector.
DIASORIN S.P.A.
DiaSorin S.p.A. is an Italy-based public company founded in 1968 with 3,242 employees. The company specializes in diagnostic solutions and immunoassay products.
EUROBIO SCIENTIFIC
Eurobio Scientific is a France-based public company founded in 1997 with 343 employees. The company operates in the life sciences and diagnostics industry.
Reasons to Buy this Report
- Regional Market Segmentation : Gain detailed insights specific to Rest Of Europe's HLA typing market, including country-level variations in adoption rates and healthcare system capabilities.
- Growth Opportunity Assessment : Identify emerging opportunities in smaller European markets with lower HLA typing penetration and understand the drivers of the 2.2% CAGR across the region.
- Competitive Landscape Analysis : Understand market dynamics, key players, and competitive positioning within Rest Of Europe's diverse healthcare environment and transplantation networks.
- Strategic Market Planning : Develop targeted expansion strategies for Rest Of Europe by understanding regional healthcare policies, reimbursement structures, and clinical demand patterns.
- Investment Decision Support : Make informed investment and partnership decisions with comprehensive market forecasts, valuation data, and growth projections through 2030 for Rest Of Europe.
Frequently asked questions
What is the market size of HLA Typing in Rest Of Europe in 2025?
The Rest Of Europe HLA Typing Market is estimated at USD 10.4 million in 2025.
What is the projected market size for Rest Of Europe HLA Typing by 2030?
Rest Of Europe HLA Typing Market is forecasted to reach USD 11.6 million by 2030.
What is the CAGR for Rest Of Europe HLA Typing Market from 2025 to 2030?
Rest Of Europe HLA Typing Market is expected to grow at a CAGR of 2.2% between 2025 and 2030.
What are the primary applications driving Rest Of Europe HLA Typing demand?
Rest Of Europe HLA Typing demand is primarily driven by organ transplantation programs, immunological diagnostics, and disease association studies in clinical laboratories.
How does Rest Of Europe HLA Typing Market growth compare to global trends?
Rest Of Europe HLA Typing Market growth at 2.2% CAGR is significantly lower than the global CAGR of 6%, indicating a more mature and stable regional market.
RESEARCH METHODOLOGY
This research study extensively utilized secondary sources, directories, and databases to identify and gather valuable information for analyzing the global HLA typing market. Additionally, in-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives from leading market players, and industry consultants. These interviews helped obtain and validate critical qualitative and quantitative data while assessing the growth prospects. The global market size, initially estimated through secondary research, was then refined and finalized through triangulation with insights from primary research.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the HLA typing market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various companies and organizations in the HLA typing market. The primary sources from the demand side include OEMs, private and contract testing organizations, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The bottom-up approach was used to estimate and validate the total size of the HLA typing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- A list of the major global players operating in the HLA typing market was generated.
- Mapping annual revenues generated by major global players from the HLA typing segment (or nearest reported business unit/service category)
- Revenue mapping of key players to cover a major share of the global market as of 2024
- Extrapolating the global value of the HLA Typing industry
Global HLA Typing Market Size: Bottom-up Approach and Top-down Approach
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
HLA typing is a genetic procedure to determine donor-recipient compatibility, cancer & autoimmune disorder diagnosis, pathogen testing, and transfusion therapy. Additionally, it is used in drug testing, disputed paternity, and anthropological studies. Advanced genomic techniques, such as PCR and NGS, are increasingly being used in HLA typing, apart from serological and other conventional techniques for immuno-compatibility testing.
Stakeholders
- HLA Typing Product Manufacturers
- Healthcare Service Providers (Hospitals, Transplant Centers, and Blood Transfusion Centers)
- Blood, Tissue, and Stem Cell Banks
- Government Organizations
- Independent Associations and Regulatory Authorities
- R&D Companies
- Independent Reference Laboratories
- Diagnostic Laboratories
- Clinical Research Organizations
- Research Laboratories and Academic Institutes
Report Objectives
- To define, describe, and forecast the HLA typing market based on technology, product & service, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth potential of the global HLA typing market (drivers, restraints, opportunities, challenges, and trends)
- To analyze the micro markets with respect to individual growth trends, future prospects, and contributions to the global HLA typing market
- To analyze key growth opportunities in the global HLA typing market for key stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa (GCC Countries and Rest of Middle East & Africa)
- To profile the key players in the HLA typing market and comprehensively analyze their market shares and core competencies
- To track and analyze the competitive developments undertaken in the global HLA typing market, such as agreements, expansions, and acquisitions
Get the Full HLA Typing Market Report
Full forecast, segment splits, and company analysis for all HLA Typing Market.
- Canada HLA Typing Market
- US HLA Typing Market
- Germany HLA Typing Market
- UK HLA Typing Market
- France HLA Typing Market
- Spain HLA Typing Market
- Italy HLA Typing Market
- China HLA Typing Market
- Japan HLA Typing Market
- India HLA Typing Market
- South Korea HLA Typing Market
- Australia HLA Typing Market
- Brazil HLA Typing Market
- Mexico HLA Typing Market
- Rest Of Asia HLA Typing Market
- Rest Of Latin America HLA Typing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
